Perivascular adipose tissue in autoimmune rheumatic diseases

Pharmacol Res. 2022 Aug:182:106354. doi: 10.1016/j.phrs.2022.106354. Epub 2022 Jul 14.

Abstract

Perivascular adipose tissue (PVAT) resides at the outermost boundary of the vascular wall, surrounding most conduit blood vessels, except for the cerebral vessels, in humans. A growing body of evidence suggests that inflammation localized within PVAT may contribute to the pathogenesis of cardiovascular disease (CVD). Patients with autoimmune rheumatic diseases (ARDs), e.g., systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), psoriasis, etc., exhibit heightened systemic inflammation and are at increased risk for CVD. Data from clinical studies in patients with ARDs support a linkage between dysfunctional adipose tissue, and PVAT in particular, in disease pathogenesis. Here, we review the data linking PVAT to the pathogenesis of CVD in patients with ARDs, focusing on the role of novel PVAT imaging techniques in defining disease risk and responses to biological therapies.

Keywords: Autoimmune rheumatic disease; Cardiovascular disease; Inflammation; Perivascular adipose tissue.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / physiology
  • Autoimmune Diseases* / complications
  • Cardiovascular Diseases* / pathology
  • Humans
  • Inflammation
  • Respiratory Distress Syndrome*
  • Rheumatic Diseases*